A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis

Fitzpatrick C, Floyd K. Pharmacoeconomics 2012; 30(1): 63-80.

The authors conducted a systematic review of the cost and cost effectiveness of treatment for MDR-TB and synthesized the available data. They concluded that treatment for MDR-TB can be cost effective in low- and middle-income countries. Evidence of the cost effectiveness of outpatient vs inpatient models of care are limited and more data is needed from Africa and Asia – though unless there is strong evidence that hospitalization is necessary to achieve high rates of adherence to treatment, patients with MDR-TB should be treated using mainly ambulatory care.

More